Skip to main content
. 2018 May 18;5(1):e000278. doi: 10.1136/bmjresp-2018-000278

Table 3.

Changes from baseline in SGRQ total and domain scores at week 52 and corresponding effect sizes by changes in FVC >10% predicted and PGI-C at week 52

Change from baseline in SGRQ score at week 52 Deterioration in FVC >10% predicted at week 52 Improvement in FVC >10% predicted at week 52 Mean (SD) difference P values PGI-C score
1–2 (very much or much better) at week 52
PGI-C score
6–7 (much or very much worse) at week 52
Mean (SD) difference P-values
n Mean (SD) Effect size n Mean (SD) Effect size n Mean (SD) Effect size n Mean (SD) Effect size
Total 152 13.1
(15.6)
0.64 21 −6.8 (15.2) −0.35 19.9 (3.6) <0.0001 116 −9.7
(14.9)
−0.55 73 20.4
(16.6)
1.20 −30.1 (2.3) <0.0001
Activity domain 154 15.6
(19.0)
0.68 22 −4.4 (17.2) −0.22 19.9 (4.3) <0.0001 118 −7.5
(17.6)
−0.37 73 20.8
(20.8)
1.11 −28.3 (2.8) <0.0001
Impact domain 153 13.2
(18.1)
0.58 21 −9.0 (18.2) −0.41 22.1 (4.2) <0.0001 116 −10.6 (18.3) −0.54 73 21.4
(18.3)
1.12 −32.0 (2.7) <0.0001
Symptoms domain 155 9.4
(20.5)
0.38 22 −3.2 (20.6) −0.14 12.6 (4.7) 0.0076 118 −9.1
(18.7)
−0.43 74 17.8
(21.4)
0.92 −27.0 (2.9) <0.0001

FVC, forced vital capacity; PGI-C, Patient ’s Global Impression of Change; SGRQ, St George’s Respiratory Questionnaire.